225 related articles for article (PubMed ID: 33674144)
1. Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.
Huang C; Lin X; He J; Liu N
Gynecol Oncol; 2021 May; 161(2):613-620. PubMed ID: 33674144
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Circulating Tumor Cells in Ovarian Cancer: A Meta-Analysis.
Zhou Y; Bian B; Yuan X; Xie G; Ma Y; Shen L
PLoS One; 2015; 10(6):e0130873. PubMed ID: 26098665
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.
Cui L; Kwong J; Wang CC
J Ovarian Res; 2015 Jun; 8():38. PubMed ID: 26077676
[TBL] [Abstract][Full Text] [Related]
5. The Predictive Value of Circulating Tumor Cells in Ovarian Cancer: A Meta Analysis.
Zeng L; Liang X; Liu Q; Yang Z
Int J Gynecol Cancer; 2017 Jul; 27(6):1109-1117. PubMed ID: 25893279
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Clinical Utility of Circulating Tumor Cells at Different Time Points in Predicting Prognosis of Patients With Small Cell Lung Cancer: A Meta-Analysis.
Jiang AM; Zheng HR; Liu N; Zhao R; Ma YY; Bai SH; Tian T; Liang X; Ruan ZP; Fu X; Yao Y
Cancer Control; 2021; 28():10732748211050581. PubMed ID: 34654345
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of epithelial-mesenchymal transition circulating tumor cells in female breast cancer: A meta-analysis.
Zhao Q; Li B; Gao Q; Luo Y; Ming L
Front Oncol; 2022; 12():1024783. PubMed ID: 36530995
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
Lu Y; Li L
Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
[No Abstract] [Full Text] [Related]
10. Association between circulating tumor cells in the peripheral blood and the prognosis of gastric cancer patients: a meta-analysis.
Jin T; Liang PP; Chen ZH; He FJ; Li ZD; Chen ZW; Hu JK; Yang K
Ther Adv Med Oncol; 2023; 15():17588359231183678. PubMed ID: 37435560
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the prognostic value of circulating tumor cells in ovarian cancer.
He X; Li S; Ni Y; Jin M; Fu X
Am J Transl Res; 2022; 14(6):3574-3583. PubMed ID: 35836887
[TBL] [Abstract][Full Text] [Related]
12. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.
Chebouti I; Kuhlmann JD; Buderath P; Weber S; Wimberger P; Bokeloh Y; Hauch S; Kimmig R; Kasimir-Bauer S
Oncotarget; 2017 Apr; 8(15):24303-24313. PubMed ID: 28388557
[TBL] [Abstract][Full Text] [Related]
13. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
[TBL] [Abstract][Full Text] [Related]
14. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis.
Jiang H; Gu X; Zuo Z; Tian G; Liu J
PLoS One; 2021; 16(7):e0254433. PubMed ID: 34242363
[TBL] [Abstract][Full Text] [Related]
16. Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer: A prospective observational study.
Kim M; Suh DH; Choi JY; Bu J; Kang YT; Kim K; No JH; Kim YB; Cho YH
Medicine (Baltimore); 2019 May; 98(20):e15354. PubMed ID: 31096435
[TBL] [Abstract][Full Text] [Related]
17. Circulating and disseminated tumor cells in pancreatic cancer and their role in patient prognosis: a systematic review and meta-analysis.
Stephenson D; Nahm C; Chua T; Gill A; Mittal A; de Reuver P; Samra J
Oncotarget; 2017 Dec; 8(63):107223-107236. PubMed ID: 29291024
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of HER2-Positive Circulating Tumor Cells in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Wang CH; Chang CJ; Yeh KY; Chang PH; Huang JS
Clin Breast Cancer; 2017 Aug; 17(5):341-349. PubMed ID: 28347604
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer.
Zhang ZY; Dai ZL; Yin XW; Li SH; Li SP; Ge HY
BMC Cancer; 2014 Oct; 14():773. PubMed ID: 25330717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]